Vialwirebiotech, curated
September 30, 2026, 8:34 PM
September 16, 2026
- 4:26 PM · BioPharma Dive4:26 PMNovartis to pay $125M for blood-brain barrier crossing platform — BioPharma Dive
- 12:00 PM · BioWorld12:00 PMXcath’s breakthrough designation advances stroke telesurgery — BioWorld
- 12:00 PM · BioWorld12:00 PMVCs hurl $123M to Sling for its oral TED treatment — BioWorld
- 9:33 AM · Bloomberg — Technology9:33 AMNovo Will Work With Anthropic AI to Speed Drug Development — Bloomberg — Technology
- 9:31 AM · SCMP — Tech9:31 AM10 AI, biotech firms in Northern Metropolis to get early cross-border data access — SCMP — Tech
- 9:31 AM · SCMP — Tech9:31 AMChina’s Z.ai raises revenue target 25% after US$5 billion cash injection — SCMP — Tech
- 9:05 AM · BioPharma Dive9:05 AMSkyhawk racks up more support for Huntington’s drug — BioPharma Dive
- 9:00 AM · BioWorld9:00 AMErnexa reports ERNA-201 data, prioritizes ERNA-101 — BioWorld
- 9:00 AM · BioWorld9:00 AMVRN-110755 shows activity in CNS-metastatic NSCLC — BioWorld
- 9:00 AM · BioWorld9:00 AMApplied Biologics unveils diabetic peripheral neuropathy program — BioWorld
- 9:00 AM · BioWorld9:00 AMElvinix licenses Zealand’s GLP-1/gastrin dual-agonist peptides — BioWorld
- 8:26 AM · Pharmaceutical Technology8:26 AMLooking beyond short-term turmoil, Syngene is investing for the future — Pharmaceutical Technology
- 8:25 AM · SCMP — Tech8:25 AMChina’s AI chip stocks face crucial test as MetaX lock-up period expires — SCMP — Tech
- 7:53 AM · SCMP — Tech
- 7:37 AM · Drug Discovery World7:37 AMMacrophage therapy trial in liver disease completes enrolment — Drug Discovery World
- 6:23 AM · Drug Discovery World6:23 AMCHMP raises concerns about microbiome therapy for GvHD — Drug Discovery World
- 5:20 AM · Pharmaceutical Technology5:20 AMGilead and PAHO agree to expedite lenacapavir access for HIV prevention — Pharmaceutical Technology
- 4:25 AM · Pharmaceutical Technology4:25 AMEli Lilly and QurCan sign genetic medicine deal — Pharmaceutical Technology
September 15, 2026
- 8:00 PM · Nature Biotechnology8:00 PMFDA approves pioneering breast cancer drug that nips resistance in the bud — Nature Biotechnology
- 5:13 PM · BioPharma Dive5:13 PMFDA clears first generic radioligand drug; Sionna turns to layoffs — BioPharma Dive
- 12:00 PM · BioWorld12:00 PM94% ORR boosts GSK’s plan for Jideytro expansion in ROS1 NSCLC — BioWorld
- 12:00 PM · BioWorld12:00 PMFEV1 well done, will FDA Connect the phase II asthma dots? — BioWorld
- 12:00 PM · BioWorld12:00 PMFDA issues second CRL to Seikagaku for condoliase BLA — BioWorld
- 12:00 PM · BioWorld12:00 PMTelix wins FDA nod for first glioma FET-PET imaging agent — BioWorld
- 12:00 PM · BioWorld12:00 PMHengrui wins world-first CIT approval for oral TPO-RA — BioWorld
- 12:00 PM · BioWorld12:00 PMEvoke-03’s miss raises bar for TROP2 ADCs in front-line NSCLC — BioWorld
- 12:00 PM · BioWorld12:00 PMFDA to explore trade-offs in rare disease statistical decisions — BioWorld
- 12:00 PM · BioWorld12:00 PMChina phase III trials make case for B7-H3 ADCs in relapsed SCLC — BioWorld
- 12:00 PM · BioWorld12:00 PMContineum fails in MDD; Definium’s LSD prospect nears NDA — BioWorld
- 11:00 AM · BioWorld11:00 AMChina-origin CTLA4 asset anchors Solstice’s $225M launch — BioWorld
- 10:13 AM · TechCrunch
- 10:00 AM · STAT News10:00 AMSTAT+: FDA takes applications for new program to shorten drug approval times — STAT News
- 10:00 AM · BioPharma Dive10:00 AMFDA launches pilot program to speed up early US drug research — BioPharma Dive
- 9:00 AM · BioWorld9:00 AMIpsen’s MAIT engager IPN-60330 set to enter clinic — BioWorld
- 9:00 AM · BioWorld9:00 AMShennon Biotechnologies raises funds to advance TCE pipeline — BioWorld
- 8:56 AM · PharmaVoice8:56 AMCocrystal Pharma’s new CEO hopes to crack the norovirus code — PharmaVoice
- 8:00 AM · BioWorld8:00 AMFinancings: Neushen raises $80M in series B — BioWorld
- 6:47 AM · Pharmaceutical Technology6:47 AMGSK bolsters oncology pipeline with $750m Chimagen TCE deal — Pharmaceutical Technology
- 6:30 AM · STAT News6:30 AMSTAT+: Vera kidney drug Trutakna shows strong final results in Phase 3 trial — STAT News
- 6:04 AM · Pharmaceutical Technology6:04 AMDefinium tees up regulatory submission for psychedelic on Phase III hat trick — Pharmaceutical Technology
- 6:00 AM · Drug Discovery World6:00 AMAI start-up receives £1m to fund its data acquisition strategy — Drug Discovery World
- 5:16 AM · Pharmaceutical Technology5:16 AMCheplapharm to take over 20 medicines and three sites from Sanofi — Pharmaceutical Technology
- 5:00 AM · Drug Discovery World5:00 AMRevvity acquires human cell model specialist — Drug Discovery World
- 4:40 AM · Pharmaceutical Technology4:40 AMFDA reduces monitoring time for Amgen’s Imdelltra infusions — Pharmaceutical Technology
- 1:00 AM · FT — Pharmaceuticals1:00 AMIt’s crunch time for BoneSupport, one of Europe’s most shorted stocks — FT — Pharmaceuticals